From genetic abnormality to metastases: murine models of breast cancer and their use in the development of anticancer therapies P.D. OttewellR.E. ColemanI. Holen Review 01 December 2005 Pages: 101 - 113
Clinical evidences of GM3 (NeuGc) ganglioside expression in human breast cancer using the 14F7 monoclonal antibody labelled with 99mTc Juan P. OlivaZodilina ValdésLuis E. Fernández OriginalPaper 02 December 2005 Pages: 115 - 121
Use of raloxifene among women with a history of breast cancer Laurel A. HabelAlice PressmanCharles P. Quesenberry Original Report 01 December 2005 Pages: 123 - 129
Bidirectional cross talk between ERα and EGFR signalling pathways regulates tamoxifen-resistant growth D.J. BrittonI.R. HutchesonR.I. Nicholson Preclinical study 27 October 2005 Pages: 131 - 146
Receptor-selective retinoids inhibit the growth of normal and malignant breast cells by inducing G1 cell cycle blockade Kendall WuElizabeth DuPréPowel H. Brown Preclinical study 05 November 2005 Pages: 147 - 157
EcoRI polymorphism of the metastasis-suppressor gene NME1 in Mexican patients with breast cancer Susan Andrea Gutierrez RubioSilvia Esperanza Flores MartinezMaria Cristina Moran Moguel Preclinical Study 30 November 2005 Pages: 159 - 161
Neuregulins 1–4 are expressed in the cytoplasm or nuclei of ductal carcinoma (in situ) of the human breast Catherine MarshallEdith BlackburnWilliam J. Gullick Preclinical study 27 October 2005 Pages: 163 - 168
Nitric oxide attenuates resistance to doxorubicin in three-dimensional aggregates of human breast carcinoma cells C.P. MuirM.A. AdamsC.H. Graham Preclinical study 06 December 2005 Pages: 169 - 176
High-resolution mapping of molecular events associated with immortalization, transformation, and progression to breast cancer in the MCF10 model Maria J. WorshamGerard PalsSandra R. Wolman Preclinical study 30 November 2005 Pages: 177 - 186
A possible regulatory role of 17β-estradiol and tamoxifen on glyoxalase I and glyoxalase II genes expression in MCF7 and BT20 human breast cancer cells Antonio RulliCinzia AntognelliVincenzo Talesa Preclinical study 01 December 2005 Pages: 187 - 196
Genetic polymorphisms of interleukin-1 beta (IL-1B) and IL-1 receptor antagonist (IL-1RN) and breast cancer risk in Korean women Kyoung-Mu LeeSue Kyung ParkDaehee Kang OriginalPaper 30 November 2005 Pages: 197 - 202